Jeffrey Bluestone is the founder of Sonoma BioTherapeutics. Sonoma BioTherapeutics has raised $40M in total funding. Latest round: Series A.
Jeffrey Bluestone is the Co-Founder of Sonoma BioTherapeutics, a biotech company established in 2019 to create treatments for autoimmune and inflammatory diseases. He previously served as CEO of the Parker Institute for Cancer Immunotherapy and launched Sonoma BioTherapeutics with a $40 million Series A financing round. Bluestone also holds positions as a Managing Director at Vie Ventures and a Board Member of Gilead Sciences.
Full founder directory · Investor directory · Company funding database · Fundraising library